Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

To earn CME related to this news article, click here. January 21, 2009 (Rochester, Minnesota) — Diastolic dysfunction is independently and strongly related to reduced exercise capacity, a new ...

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced initial dosing in a Phase 1 trial of EDG-7500.

MR angiograms (top row) of the right coronary arteries in two persons living with HIV (PLWH) show location of cross-section (dotted lines) of coronary vessel wall image (bottom row) and the ...